On June 24th, Gelunhui reported that Junshengtai Medicine-B (2511.HK) plummeted on heavy volume, with a drop of over 61% to HKD 1.38 at one point during the day. The stock price hit a new low since its listing on December 22nd of last year, and has fallen by more than 88% this year. Junshengtai Medicine is a global, integrated biopharmaceutical company dedicated to discovering, developing, and commercializing first-in-class, multi-functional, multi-target therapies to treat metabolic and digestive system diseases.
港股异动丨君圣泰医药盘中暴跌61% 股价创上市以来新低
Hong Kong stocks: Jun Shengtai Pharmaceutical plummeted 61% in intraday trading, hitting a new low since listing.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.